Shukra Pharmaceuticals Limited has secured a ₹24.06 crore contract from HSCC (India) Ltd, under the Ministry of External Affairs, for supplying medicines and diagnostic kits to Afghanistan. The Letter of Award dated August 28, 2025, covers supply, packing, forwarding, insurance, and delivery in Kabul. The company expects this deal to enhance growth, brand positioning, and stakeholder value.